MassMEDIC: The Massachusetts Medical Device Industry Council

Willis M. Emmons III; Michael E. Porter; Spencer   Wallace

Case | HBS Case Collection | June 2006 (Revised July 2009)

MassMEDIC: The Massachusetts Medical Device Industry Council

by Willis M. Emmons III, Michael E. Porter and Spencer Wallace

Abstract

Set in 2004, as Massachusetts Medical Device Industry Council (MassMEDIC) President Tom Sommer contemplates the future direction of a successful medical device cluster association. Focuses on the formation of cluster organizations and their roles and effectiveness, highlighting the importance of these organizations in enabling cross-cluster collaboration between firms, universities, regulators and other government officials, and other institutions. Details the events that led to the formation of MassMEDIC and the initial challenges the organization faced. Discusses the evolution of MassMEDIC's activities, from its formation in 1996 through 2004, and the views of different MassMEDIC stakeholders on the future direction of the organization. Provides detailed data about MassMEDIC and the Massachusetts medical device cluster to enable an evaluation of results and inform future direction.

Keywords: Economic Growth; Industry Clusters; Nonprofit Organizations; Social and Collaborative Networks; Cooperation; Massachusetts;

Format: Print

26 pages

Educators Purchase

Citation:

Emmons, Willis M., III, Michael E. Porter, and Spencer Wallace. "MassMEDIC: The Massachusetts Medical Device Industry Council." Harvard Business School Case 706-498, June 2006. (Revised July 2009.)

Since its establishment in 2005, Hamburg’s Martini Klinik had single mindedly focused on prostate cancer care with a commitment to measure long-term health outcomes for every patient. A wholly owned subsidiary of the University Hospital Hamburg, Martini Klinik was a “hospital in a hospital” in close proximity to other medical departments and services. By 2019, Martini Klinik had become the largest prostate cancer treatment program in the world with 8,000 outpatient cases and more than 2,500 surgical cases annually. Patients came from all over Germany and from around the world. A new and expanded facility was under construction to have the capacity to manage more patients with prostate cancer.

In this report, the authors synthesize their views on U.S. competitiveness and unveil the findings of the 2019 HBS surveys on U.S. competitiveness. Specifically, this report—built on the survey findings and eight years of prior research on the competitiveness of the United States—highlights a disturbing pattern: despite a decade of steady economic growth since the Great Recession, America has done remarkably little to address underlying structural weaknesses in the country’s economy and society. The nation has squandered the recovery.

Currently, few health care providers measure and report their patient outcomes, which leads to several problems. Attempts to introduce price transparency without outcomes transparency could trigger a “race to the bottom.” Should Medicare coverage be expanded to non-elderly populations, its much lower reimbursements will create pressure on providers to lower their spending in ways that produce even worse outcomes. Even without Medicare expansion, the lack of systematic outcomes measurement has made the migration from fee-for-service to value-based reimbursements, especially bundled payments, less effective and more difficult to implement. Hidden variation in outcomes prevents providers from learning from others how to produce better outcomes for their patients. We propose that the Congress elected in November 2020 mandate the Centers for Medicare and Medicaid Services to begin requiring outcomes measurement by all providers reimbursed under government Medicare and Medicaid programs.

Faculty & Research

MassMEDIC: The Massachusetts Medical Device Industry Council

Abstract

Citation:

About the Authors

More from these Authors